HigoSense Company Profile

Background

Founded in 2017 and headquartered in Warsaw, Poland, HigoSense is a digital healthcare provider specializing in remote medical diagnostics. The company's mission is to deliver enhanced patient experiences and improved efficiency for healthcare providers by enabling high-quality remote examinations. HigoSense has developed a mobile medical examination device, supported by a mobile app and an AI-powered health diagnostic platform, allowing both physicians and patients to perform comprehensive remote examinations.

Key Strategic Focus

HigoSense focuses on revolutionizing telemedicine by providing tools that replicate in-person examinations remotely. Their core objectives include expanding access to healthcare, reducing diagnostic costs, and shortening the time required for accurate diagnoses. The company's primary markets encompass Europe, the Middle East, and Asia, targeting healthcare providers, insurance companies, and individual consumers seeking efficient telehealth solutions.

Financials and Funding

As of December 2021, HigoSense has raised a total of €8 million in funding. The most recent Series A funding round, amounting to €5 million, was led by Cogito Capital Partners, with participation from early-stage investors, including the founders of RTB House. The capital is intended to support the company's expansion into new markets across Europe, the Middle East, and Asia.

Pipeline Development

HigoSense's primary product is the Higo® device, a modular examination tool designed for remote diagnostics. The device has obtained EU medical device certification and is commercially available. The company continues to enhance its product offerings by integrating advanced AI algorithms and expanding its telehealth platform to cater to a broader range of medical conditions and user needs.

Technological Platform and Innovation

HigoSense's innovation lies in its proprietary Higo® device, which includes five interchangeable modules:

Thermometer: Measures body temperature.

Throat Spatula: Facilitates throat examinations.

Stethoscope: Records heart and lung sounds.

Otoscope: Examines the ear canal and eardrum.

Derm Hood: Captures high-resolution images of the skin.

These modules enable comprehensive remote examinations, guided by an AI-powered mobile app that ensures correct usage and provides instant access to health records. The platform's AI algorithms enhance patient experience and support physicians in analyzing medical data collected during remote sessions.

Leadership Team

Łukasz Krasnopolski: Co-Founder and CEO. Brings extensive experience in healthcare innovation and business development.

Michał Biernat: Co-Founder and CTO. Specializes in technology development and project management within the medtech sector.

Both leaders have been instrumental in guiding HigoSense's strategic direction and technological advancements.

Competitor Profile

Market Insights and Dynamics

The telemedicine market has experienced rapid growth, further accelerated by the COVID-19 pandemic. In Europe, the market is projected to expand from $12.8 billion in 2019 to $49.1 billion by 2026. This growth is driven by increased adoption of digital health solutions and supportive regulatory changes.

Competitor Analysis

HigoSense operates in a competitive landscape with several notable companies:

oDoc: Provides a B2B telemedicine app facilitating remote consultations.

Chunyu Yisheng: Offers an online platform for remote physician consultations, appointment scheduling, and medical record management.

Udo: Develops a video-based healthcare collaboration app.

Scene and Scene Health: Focuses on improving patient adherence and strengthening patient-provider relationships through mobile health solutions.

These competitors emphasize various aspects of telemedicine, from consultation platforms to patient engagement tools.

Strategic Collaborations and Partnerships

HigoSense collaborates with over 50 top experts from countries including the Netherlands, Germany, Spain, France, and Poland to ensure the excellence of its products. The company also works closely with outstanding doctors from institutions such as the Medical University of Warsaw and the Children's Clinical Hospital in Warsaw, who contribute their time and knowledge to develop the medicine of the future.

Operational Insights

HigoSense differentiates itself by offering a comprehensive remote diagnostic solution that combines hardware, software, and AI capabilities. This integrated approach provides a more thorough examination experience compared to competitors focusing solely on teleconsultation platforms. The company's emphasis on high-quality medical data and user-friendly design enhances its market position.

Strategic Opportunities and Future Directions

HigoSense aims to capitalize on the growing telemedicine market by expanding its presence in Europe, the Middle East, and Asia. The company plans to enhance its product offerings by integrating more advanced AI algorithms and expanding its telehealth platform to cater to a broader range of medical conditions and user needs. By leveraging its current strengths in technology and strategic partnerships, HigoSense is well-positioned to achieve its future objectives.